Marinus Pharmaceuticals Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	-	-	-	-	76.44	66.73	Upgrade
Depreciation & Amortization	-	-	-	-	67.19	38.68	Upgrade
Change in Other Net Operating Assets	-	-	-	-	129.3	-998.08	Upgrade
Other Operating Activities	-	-	-	-	44.98	106.03	Upgrade
Operating Cash Flow	-	-	-	-	317.91	-786.64	Upgrade
Capital Expenditures	-	-	-	-	-22.99	-38.31	Upgrade
Sale of Property, Plant and Equipment	-	-	-	-	56.59	129.13	Upgrade
Investment in Securities	-	-	-	-	160.33	-114.8	Upgrade
Investing Cash Flow	-	-	-	-	193.92	-23.98	Upgrade
Long-Term Debt Repaid	-	-	-	-	-53.94	-22.47	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	-53.94	-22.47	Upgrade
Common Dividends Paid	-	-	-	-	-33	-	Upgrade
Net Increase (Decrease) in Deposit Accounts	-	-	-	-	-331.38	574.23	Upgrade
Other Financing Activities	-	-	-	-	-	0	Upgrade
Financing Cash Flow	-	-	-	-	-418.32	551.76	Upgrade
Foreign Exchange Rate Adjustments	-	-	-	-	-6.09	30.03	Upgrade
Net Cash Flow	-	-	-	-	87.43	-228.83	Upgrade
Free Cash Flow	-	-	-	-	294.92	-824.95	Upgrade
Free Cash Flow Margin	-	-	-	-	54.40%	-177.40%	Upgrade
Free Cash Flow Per Share	-	-	-	-	0.01	-0.04	Upgrade
Cash Interest Paid	-	-	-	-	188.46	236.47	Upgrade
Cash Income Tax Paid	-	-	-	-	22.56	22.81	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.